RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; Machine Learning; and Liver Ablation Solutions. The company was founded in 2000 and is headquartered in Stockholm, Sweden.
Frequently asked questions
What sector does RaySearch Laboratories AB (publ) (27R) operate in?
RaySearch Laboratories AB (publ) belongs to the Healthcare sector and operates in the Health Information Services industry.
What is RaySearch Laboratories AB (publ) (27R) current stock price?
As of the latest data, RaySearch Laboratories AB (publ) stock price is €14.77, with a previous close of €15.13. RaySearch Laboratories AB (publ) lost -€0.36 in the last trading session, representing a -2.38% loss.
What is RaySearch Laboratories AB (publ) (27R) current market capitalization?
RaySearch Laboratories AB (publ) market cap is approximately 440.20 million.
What is RaySearch Laboratories AB (publ) (27R) Earnings Per Share (EPS)?
The trailing EPS is €0.55.
What is RaySearch Laboratories AB (publ) (27R) Price-to-Earnings (P/E) ratio?
RaySearch Laboratories AB (publ) current P/E ratio is 26.85.
Does RaySearch Laboratories AB (publ) (27R) pay dividends?
Yes. RaySearch Laboratories AB (publ) pays annual dividends with an annualized yield of 0.21% and an estimated annual payout of €0.35 per share.
When is the next ex-dividend date for RaySearch Laboratories AB (publ) (27R)?
The next ex-dividend date is scheduled for May 08, 2027.
When is RaySearch Laboratories AB (publ) (27R) next earnings report?
RaySearch Laboratories AB (publ) is expected to release its next earnings report on September 30, 2026.
What is RaySearch Laboratories AB (publ) (27R) beta (volatility) score?
RaySearch Laboratories AB (publ) has a beta of 0.920, meaning its volatility is roughly in line with the market.
